Jeffrey Clark, MD, is the medical director of Clinical Trials Infrastructure/Support for the Harvard Cancer Consortium, which facilitates clinical trials across the Mass General Cancer Center, Brigham and Women’s Hospital, the Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center, the Harvard School of Public Health and Boston Children’s Hospital. Together, the Harvard hospitals form the largest comprehensive cancer center in the world. Clinical trials are the vehicle for introducing vital new therapies into clinical practice. Dr. Clark oversees key aspects of the delivery of potentially breakthrough treatments to patients with all types of cancer.
Dr. Clark’s own medical oncology practice and research focus on patients with pancreatic and gastrointestinal cancers. He is best known for engaging his patients in creating an integrated plan for their own treatment.
Vicci Recckio, Dr. Clark’s patient for the past two years, writes,” Dr. Clark and I were partners in my complete healing. That is unusual to find between a doctor and a patient. He listens to my suggestions and feelings and always takes them into consideration.
“One time I was scared, and he told me my situation was ‘hurdleable,’ a word he made up, but one that was encouraging and cautiously optimistic. If it weren’t for Dr. Clark and his team, I’m convinced I would not be here today to write this.”
